Pharmaceutical

Theralase(R) Closes $CAN 750,000 Non-Brokered Private PlacementTheralase(R) Closes $CAN 750,000 Non-Brokered Private Placement

Theralase(R) Closes $CAN 750,000 Non-Brokered Private Placement

TORONTO, ON / ACCESSWIRE / April 24, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF)(FRA:TTX), a clinical stage…

9 months ago
Nutriband Closes $8.4M Private Placement for Commercial Development of Aversa(R) Fentanyl Transdermal Patch Through FDA SubmissionNutriband Closes $8.4M Private Placement for Commercial Development of Aversa(R) Fentanyl Transdermal Patch Through FDA Submission

Nutriband Closes $8.4M Private Placement for Commercial Development of Aversa(R) Fentanyl Transdermal Patch Through FDA Submission

Private Placement of $8.4 million has closed and will fund the commercial development of lead product AVERSA Fentanyl to NDA…

9 months ago
Spago Nanomedical Reports Favorable Data in Breast Cancer Model with TumoradSpago Nanomedical Reports Favorable Data in Breast Cancer Model with Tumorad

Spago Nanomedical Reports Favorable Data in Breast Cancer Model with Tumorad

LUND, SWEDEN / ACCESSWIRE / April 24, 2024 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) Spago Nanomedical AB (publ) announced today data from…

9 months ago
Angle PLC Announces New Commercial Agreement with AstraZenecaAngle PLC Announces New Commercial Agreement with AstraZeneca

Angle PLC Announces New Commercial Agreement with AstraZeneca

ANGLE signs agreement to tailor existing Parsortix-based DNA damage response assay for use in pharmaceutical R&D GUILDFORD, SURREY / ACCESSWIRE…

9 months ago
Evotec Presents Fiscal Year 2023 Results and Announces Priority Reset to Focus on Profitable GrowthEvotec Presents Fiscal Year 2023 Results and Announces Priority Reset to Focus on Profitable Growth

Evotec Presents Fiscal Year 2023 Results and Announces Priority Reset to Focus on Profitable Growth

FINANCIAL RESULTS FOR 2023 FULLY MET UPDATED GUIDANCEPRIORITY RESET TO PROFITABLE GROWTH: SIZE & FOOTPRINT ADJUSTMENTS TO DRIVE EXPECTED ANNUALISED…

9 months ago
Medicure Receives US FDA Fast Track Designation for MC-1 for PNPO DeficiencyMedicure Receives US FDA Fast Track Designation for MC-1 for PNPO Deficiency

Medicure Receives US FDA Fast Track Designation for MC-1 for PNPO Deficiency

WINNIPEG, MB / ACCESSWIRE / April 23, 2024 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused…

9 months ago
Laxxon Medical to Participate in the World Orphan Drug Congress USA 2024Laxxon Medical to Participate in the World Orphan Drug Congress USA 2024

Laxxon Medical to Participate in the World Orphan Drug Congress USA 2024

NEW YORK, NY / ACCESSWIRE / April 23, 2024 / Laxxon Medical, a leading 3D screen printing platform technology company,…

9 months ago
Evotec SE appoints Dr Christian Wojczewski as Chief Executive OfficerEvotec SE appoints Dr Christian Wojczewski as Chief Executive Officer

Evotec SE appoints Dr Christian Wojczewski as Chief Executive Officer

HAMBURG, GERMANY / ACCESSWIRE / April 23, 2024 / The Supervisory Board of Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX,…

9 months ago
Newtopia Now, August Launch Event from New Hope Network, Unveils First Reveal of Neighborhood ConceptNewtopia Now, August Launch Event from New Hope Network, Unveils First Reveal of Neighborhood Concept

Newtopia Now, August Launch Event from New Hope Network, Unveils First Reveal of Neighborhood Concept

Focus on curated brand-to-buyer experience and enhanced matchmaking offers opportunities for deep relationship building, connecting brands to key retailers, press…

9 months ago
Red Light Holland Initiates Psilocybin Extraction Phase with PharmAla Following Successful Testing and Preparation by CCrest LabsRed Light Holland Initiates Psilocybin Extraction Phase with PharmAla Following Successful Testing and Preparation by CCrest Labs

Red Light Holland Initiates Psilocybin Extraction Phase with PharmAla Following Successful Testing and Preparation by CCrest Labs

Toronto, Ontario--(Newsfile Corp. - April 23, 2024) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light…

9 months ago